| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |